Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin for Premature Birth Prevention in Preterm Labor
NCT02056899Phase 1Completed
- Sponsor
- University at Buffalo
- Start
- Jun 2013
- Primary completion
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of gabapentin in preterm birth, sponsored by University at Buffalo. Primary endpoint: Rate of premature birth (before 37 weeks gestation). Started Jun 2013; status: completed.
02
Drugs
gabapentin
03
Conditions
preterm birth
Beyond the preview
Go deeper on NCT02056899.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02056899.